Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
|
| gptkbp:abandonedDevelopment |
true
|
| gptkbp:alternativeName |
gptkb:emivirine
|
| gptkbp:CASNumber |
172673-49-3
|
| gptkbp:chemicalFormula |
C13H14N4O2
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
HIV treatment
|
| gptkbp:developmentType |
discontinued
|
| gptkbp:discoveredBy |
gptkb:Janssen_Pharmaceutica
|
| gptkbp:drugClass |
non-nucleoside reverse transcriptase inhibitor
|
| https://www.w3.org/2000/01/rdf-schema#label |
VER-155008
|
| gptkbp:IUPACName |
6-benzyl-1-(ethoxymethyl)-5-isopropyluracil
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL19010
151194 |
| gptkbp:target |
HIV-1 reverse transcriptase
|
| gptkbp:bfsParent |
gptkb:HSP70
gptkb:Hsp70 |
| gptkbp:bfsLayer |
7
|